$GOAI
Eva Live Inc

2023 Q4 Form 10-Q Financial Statement

#000149315223040360 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $1.699M $1.080M
YoY Change 709.17%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.209M $599.1K
YoY Change 137.34%
Operating Profit $490.0K $480.5K
YoY Change -263.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $490.0K $480.5K
YoY Change -263.61%
Income Tax
% Of Pretax Income
Net Earnings $490.0K $480.5K
YoY Change -263.61%
Net Earnings / Revenue 28.84% 44.51%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 115.8M shares 115.8M shares 115.6M shares
Diluted Shares Outstanding 115.8M shares 115.6M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $472.5K $555.3K $23.73K
Short-Term Investments
Other Short-Term Assets $269.00
YoY Change -80.85%
Inventory
Prepaid Expenses
Receivables $1.595M $933.5K
Other Receivables
Total Short-Term Assets $2.068M $1.490M
YoY Change 729.22%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $2.011M $2.011M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.011M $2.041M
YoY Change -8.78%
TOTAL ASSETS
Total Short-Term Assets $2.068M $1.490M
Total Long-Term Assets $2.011M $2.041M
Total Assets $4.078M $3.531M
YoY Change 66.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.129M $1.957M
YoY Change 22.23%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.129M $1.957M
Total Long-Term Liabilities
Total Liabilities $2.129M $1.998M
YoY Change 19.43%
SHAREHOLDERS EQUITY
Retained Earnings -$24.18M -$17.27M
YoY Change 33.34%
Common Stock $12.31K $11.59K
YoY Change 6.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.949M $1.533M $1.043M
YoY Change
Total Liabilities & Shareholders Equity $4.078M $3.531M
YoY Change 66.23%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $490.0K $480.5K
YoY Change -263.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001983736
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
GOAI Common Stock Issued For Services
CommonStockIssuedForServices
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
GOAI Reverse Merger Adjustments
ReverseMergerAdjustments
usd
GOAI Goodwill Impairment Investing Activities
GoodwillImpairmentInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Stock Issued1
StockIssued1
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-273162
dei Entity Registrant Name
EntityRegistrantName
EVA LIVE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-2864075
dei Entity Address Address Line1
EntityAddressAddressLine1
The Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
1800 Century Park East
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 600
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90067
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
229-5981
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
GOAI
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
115847349 shares
CY2023Q3 us-gaap Cash
Cash
555303 usd
CY2022Q4 us-gaap Cash
Cash
38506 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
183744 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
156307 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
933514 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209442 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
1405 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
1405 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1490222 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
249353 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2010606 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2010606 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
30164 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
193497 usd
CY2023Q3 us-gaap Assets
Assets
3530992 usd
CY2022Q4 us-gaap Assets
Assets
2453456 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1832194 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1535707 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1956822 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1741687 usd
CY2023Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
40832 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
40832 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1997654 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1782519 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115847349 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115847349 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115847349 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115847349 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
11585 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11585 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18790939 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18790939 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17269186 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18131587 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1533338 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
670937 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3530992 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2453456 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1699173 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209990 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3124652 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1049135 usd
CY2023Q3 us-gaap Revenues
Revenues
1699173 usd
CY2022Q3 us-gaap Revenues
Revenues
209990 usd
us-gaap Revenues
Revenues
3124652 usd
us-gaap Revenues
Revenues
1049135 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
175740 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
305730 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
518746 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1440029 usd
CY2023Q3 GOAI Media Traffic Purchase Expense
MediaTrafficPurchaseExpense
979000 usd
CY2022Q3 GOAI Media Traffic Purchase Expense
MediaTrafficPurchaseExpense
149304 usd
GOAI Media Traffic Purchase Expense
MediaTrafficPurchaseExpense
1580172 usd
GOAI Media Traffic Purchase Expense
MediaTrafficPurchaseExpense
931000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54444 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54444 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
163333 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
163333 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1209184 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
509478 usd
us-gaap Operating Expenses
OperatingExpenses
2262251 usd
us-gaap Operating Expenses
OperatingExpenses
2989396 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
489989 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-299488 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
862401 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1940261 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
489989 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-299488 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
862401 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1940261 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
489989 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-299488 usd
us-gaap Net Income Loss
NetIncomeLoss
862401 usd
us-gaap Net Income Loss
NetIncomeLoss
-1940261 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115847349 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115847349 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115640215 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115640215 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115847349 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115847349 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115174570 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115174570 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
879200 usd
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
168800 usd
CY2022Q3 us-gaap Share Price
SharePrice
1.00
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25024 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1500000 usd
CY2022Q3 GOAI Adjustment To Additional Paid In Capital Accounting Acquirer Adjustments
AdjustmentToAdditionalPaidInCapitalAccountingAcquirerAdjustments
50048 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-299488 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2323584 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1043349 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
489989 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1533338 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2079972 usd
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
168800 usd
CY2022Q3 us-gaap Share Price
SharePrice
1.00
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25024 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1500000 usd
GOAI Adjustment To Additional Paid In Capital Accounting Acquirer Adjustments
AdjustmentToAdditionalPaidInCapitalAccountingAcquirerAdjustments
50048 usd
us-gaap Net Income Loss
NetIncomeLoss
-1940261 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2323584 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
670937 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
670937 usd
us-gaap Net Income Loss
NetIncomeLoss
862401 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1533338 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1533338 usd
us-gaap Net Income Loss
NetIncomeLoss
862401 usd
us-gaap Net Income Loss
NetIncomeLoss
-1940261 usd
GOAI Common Stock Issued For Services
CommonStockIssuedForServices
25024 usd
us-gaap Depreciation
Depreciation
163333 usd
us-gaap Depreciation
Depreciation
163333 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
724072 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
93521 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-875875 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
296487 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
293133 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-81352 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
8867 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
516797 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-667550 usd
GOAI Reverse Merger Adjustments
ReverseMergerAdjustments
-50048 usd
GOAI Goodwill Impairment Investing Activities
GoodwillImpairmentInvestingActivities
-1500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1449952 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
608800 usd
us-gaap Stock Issued1
StockIssued1
1500000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2108800 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
516797 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8702 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38506 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33523 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
555303 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24821 usd
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company completed a reverse split in the amount of 1 for 150
CY2021Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
55909 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27437 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_z3S4yOMlKT0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zJ72UhyLmgj2">Financial Statement Preparation and Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Cash
Cash
555303 usd
CY2022Q4 us-gaap Cash
Cash
38506 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
183744 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
156307 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z0Ol297jpv23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z0BqgH5sGrtj">Concentrations of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of Cash. The Company places its Cash with a major banking institution. The Company did <span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_do_c20221231_zX7NGRXrYlKa" title="Federal deposit insurance">no</span>t have cash balances over the Federal Deposit Insurance Corporation limit on December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115847349 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115847349 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114713525 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114713525 shares
us-gaap Net Income Loss
NetIncomeLoss
-1940261 usd
us-gaap Net Income Loss
NetIncomeLoss
862401 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17269186 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18131587 usd
us-gaap Net Income Loss
NetIncomeLoss
862401 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1940261 usd
CY2023Q3 GOAI Working Capital Deficincy
WorkingCapitalDeficincy
-466600 usd
CY2022Q4 GOAI Working Capital Deficincy
WorkingCapitalDeficincy
-1492334 usd
CY2023Q3 us-gaap Cash
Cash
555303 usd
CY2022Q4 us-gaap Cash
Cash
38506 usd
CY2023Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
778783 usd
CY2023Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
748619 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
30164 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
778783 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
596207 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
193497 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115847349 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115847349 shares

Files In Submission

Name View Source Status
0001493152-23-040360-index-headers.html Edgar Link pending
0001493152-23-040360-index.html Edgar Link pending
0001493152-23-040360.txt Edgar Link pending
0001493152-23-040360-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
goai-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
goai-20230930_def.xml Edgar Link unprocessable
goai-20230930_lab.xml Edgar Link unprocessable
goai-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
goai-20230930_cal.xml Edgar Link unprocessable